Cash Flow Statement

Currency: USD

	Mar-2022	Jun-2022	Sep-2022	Dec-2022	Mar-2023	Jun-2023	Sep-2023	Dec-2023	Mar-2024	Jun-2024	Sep-2024	Dec-2024	Mar-2025	Jun-2025	Sep-2025
Operating Cash Flow
Net Income	(10)	(13)	(15)	(18)	(19)	(19)	(20)	(19)	(17)	(18)	(15)	(17)	(26)	(25)	(27)
Depreciation & Amortization	0	0	0	0	0	0	0	0	0	0	0	0	0	(0)	(0)
Stock-Based Compensation	0	0	0	0	0	0	1	1	1	2	2	2	2	1	1
Other Non-Cash Items	1	0	0	0	1	1	1	1	1	2	2	4	13	12	12
Cash Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Working Capital	(0)	1	2	1	2	0	2	(1)	(2)	(0)	(3)	(0)	0	(2)	1
Cash from Operating Activities	(9) N/A	(12) -30%	(13) -11%	(16) -18%	(16) -4%	(17) -6%	(16) +5%	(18) -10%	(17) +3%	(15) +12%	(16) -3%	(13) +16%	(12) +6%	(14) -15%	(15) -1%
Investing Cash Flow
Capital Expenditures	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	0	0	0
Other Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash from Investing Activities	(0) N/A	(0) +20%	(0) +32%	(0) +35%	(0) +18%	(0) +29%	(0) -8%	(0) +44%	(0) +26%	(0) +51%	(0) -64%	(0) -2%	0 N/A	0 N/A	0 N/A
Financing Cash Flow
Net Issuance of Common Stock	26	26	0	0	1	8	15	16	21	15	10	16	19	18	16
Other	0	(1)	(0)	0	0	(0)	0	0	0	0	0	0	0	0	(0)
Cash from Financing Activities	26 N/A	26 +0%	(0) N/A	0 N/A	1 +19 578%	8 +539%	15 +101%	16 +5%	21 +31%	15 -27%	10 -32%	16 +59%	19 +17%	18 -4%	15 -16%
Change in Cash
Net Change in Cash	16 N/A	13 -17%	(14) N/A	(16) -16%	(15) +4%	(10) +35%	(1) +86%	(2) -65%	3 N/A	(0) N/A	(6) -2 461%	3 N/A	7 +119%	4 -40%	1 -76%
Free Cash Flow
Free Cash Flow	(10) N/A	(12) -29%	(14) -10%	(16) -17%	(16) -3%	(17) -6%	(16) +5%	(18) -10%	(18) +3%	(15) +12%	(16) -3%	(13) +16%	(12) +6%	(14) -15%	(15) -1%

Transcode Therapeutics Inc
NASDAQ:RNAZ